Powder extensively hydrolysed formula (0913101) vs Pdr disc/non ACBS protein SfI metabolic condition (0913445)
Powder extensively hydrolysed formula (0913101) was dispensed 596.6× as often as Pdr disc/non ACBS protein SfI metabolic condition (0913445) in March 2026 — 41,759 items versus 70 in England.
41,759items
Powder extensively hydrolysed formula (0913101) · March 2026
NHSBSA Prescription Cost Analysis
70items
Pdr disc/non ACBS protein SfI metabolic condition (0913445) · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Powder extensively hydrolysed formula (0913101) versus Pdr disc/non ACBS protein SfI metabolic condition (0913445): national items dispensed by month
▬ Powder extensively hydrolysed formula (0913101) · ╌ Pdr disc/non ACBS protein SfI metabolic condition (0913445)
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Powder extensively hydrolysed formula (0913101) | Pdr disc/non ACBS protein SfI metabolic condition (0913445) |
|---|---|---|
| Items, March 2026 | 41,759 | 70 |
| Items, last 12 months | 490,419 | 851 |
| Net ingredient cost, March 2026 | £3,118,227 | £45,716 |
See the full profile for Powder extensively hydrolysed formula (0913101) or Pdr disc/non ACBS protein SfI metabolic condition (0913445).